Similarly, asthma patients receiving conventional therapy alongside six months of oral choline supplementation exhibited significant reductions in circulating eosinophils and factors involved in bronchial hyperreactivity, such as IL-5 and cysteinyl leukotrienes (Cys-LT) (94). The gene discussed is IL5; the disease is asthma.